NOTCH3 and metabolic disease: This study found that miR-204-5p inhibited adipocyte differentiation by acting on the AMPK signaling pathway and the JAG1/NOTCH3 axis, suggesting potential targets for the treatment of obesity and other related metabolic diseases.